Shandong Pharmaceutical Glass Co Ltd (600529) — Cash Flow-to-Debt Ratio
Shandong Pharmaceutical Glass Co Ltd (600529) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of CN¥41.46 Million could theoretically repay 0% of its total liabilities (CN¥1.75 Billion) in one year. Explore Shandong Pharmaceutical Glass Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Pharmaceutical Glass Co Ltd Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Shandong Pharmaceutical Glass Co Ltd across 25 annual periods. Also explore Shandong Pharmaceutical Glass Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Year-by-year debt coverage analysis for Shandong Pharmaceutical Glass Co Ltd. For market capitalisation and broader financial context, see 600529 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥576.92 Million | CN¥1.75 Billion | ▼ -39.6% |
| 2024 | 0.55x | CN¥1.17 Billion | CN¥2.13 Billion | ▼ -7.0% |
| 2023 | 0.59x | CN¥1.05 Billion | CN¥1.78 Billion | ▲ +324.1% |
| 2022 | 0.14x | CN¥252.44 Million | CN¥1.82 Billion | ▼ -67.9% |
| 2021 | 0.43x | CN¥750.44 Million | CN¥1.74 Billion | ▲ +4.1% |
| 2020 | 0.41x | CN¥566.01 Million | CN¥1.37 Billion | ▼ -9.9% |
| 2019 | 0.46x | CN¥599.05 Million | CN¥1.30 Billion | ▲ +8.4% |
| 2018 | 0.42x | CN¥465.77 Million | CN¥1.10 Billion | ▼ -4.3% |
| 2017 | 0.44x | CN¥411.96 Million | CN¥929.84 Million | ▼ -24.7% |
| 2016 | 0.59x | CN¥506.53 Million | CN¥860.62 Million | ▲ +11.1% |
| 2015 | 0.53x | CN¥389.63 Million | CN¥735.61 Million | ▲ +37.6% |
| 2014 | 0.38x | CN¥266.63 Million | CN¥692.56 Million | ▼ -3.2% |
| 2013 | 0.40x | CN¥268.60 Million | CN¥675.48 Million | ▲ +836.7% |
| 2012 | 0.04x | CN¥28.52 Million | CN¥671.80 Million | ▼ -90.0% |
| 2011 | 0.43x | CN¥274.63 Million | CN¥644.80 Million | ▲ +52.8% |
| 2010 | 0.28x | CN¥217.01 Million | CN¥778.34 Million | ▼ -30.3% |
| 2009 | 0.40x | CN¥249.27 Million | CN¥623.51 Million | ▲ +132.9% |
| 2008 | 0.17x | CN¥91.76 Million | CN¥534.52 Million | ▼ -21.0% |
| 2007 | 0.22x | CN¥122.63 Million | CN¥564.66 Million | ▲ +95.4% |
| 2006 | 0.11x | CN¥78.47 Million | CN¥705.86 Million | ▲ +42.3% |
| 2005 | 0.08x | CN¥44.09 Million | CN¥564.27 Million | ▲ +1018.5% |
| 2004 | -0.01x | CN¥-3.70 Million | CN¥434.85 Million | ▼ -104.5% |
| 2003 | 0.19x | CN¥59.35 Million | CN¥310.80 Million | ▼ -48.7% |
| 2002 | 0.37x | CN¥109.26 Million | CN¥293.28 Million | ▲ +216.4% |
| 2001 | 0.12x | CN¥28.60 Million | CN¥242.90 Million | — |